Literature DB >> 9773483

Cell proliferation and its evaluation in the colorectal mucosa: effect of ethanol.

H K Seitz1, U A Simanowski, N Homann, R Waldherr.   

Abstract

Colorectal cell turn over is affected by numerous factors including diets, alcohol consumption, smoking or age and is also significantly changed in certain mucosal diseases including benign and malignant tumors. Mucosal hyperregeneration is associated with an increased cancer risk since it increases the susceptibility of the mucosa towards the action of carcinogens. The measurement of colorectal mucosal regenerativity can be used for risk assessment in carcinogenesis. For the evaluation of colorectal regeneration in vivo and in vitro methods exist. The most accurate and elegant in vivo method is the metaphase arrest technique which is a dynamic measurement of cell turn over using vincristine to arrest metaphase figures. This method is limited to animals. In man, colorectal biopsies can be incubated with tritiated thymidine or with bromodeoxyuridine and thereafter the incorporation of the two compounds into DNA can be visualized by autoradiography or by immunohistology. More recent developments include the use of antibodies against certain proteins which are closely related to certain phases of the cell cycle and which are expressed in dividing cells. The most frequently used proteins are proliferative cellular nuclear antigen (PCNA) and Ki-67 which are visualized by immunohistology in routinely fixed histological specimens. Finally, in situ hybridization of histone H3 mRNA which is almost exclusively expressed during S-phase, has been established as an excellent method for the determination of colorectal cell regeneration. In conclusion, chronic alcohol consumption both in animals and in man leads to mucosal cellular hyperregeneration, possibly secondary to mucosal injury, most likely due to acetaldehyde. The acetaldehyde is produced mainly by fecal bacteria and may exert its toxicity by mechanisms still unknown, possibly involving a direct effect on DNA. The ethanol-associated mucosal hyperregeneration is closely related to carcinogenesis since chronic ethanol ingestion leads to an increased risk of cancer in the colorectum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773483

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  7 in total

1.  Inhibition of retinol oxidation by ethanol in the rat liver and colon.

Authors:  A Parlesak; I Menzl; A Feuchter; J C Bode; C Bode
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  To best measure cell proliferation in samples from the intestine.

Authors:  D Alferez; R A Goodlad
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

Review 3.  Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality?

Authors:  Katia Lofano; Mariabeatrice Principi; Maria Principia Scavo; Maria Pricci; Enzo Ierardi; Alfredo Di Leo
Journal:  J Gastrointest Cancer       Date:  2013-03

4.  Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma.

Authors:  Michael A Kuefner; Hubert G Schwelberger; Eckhart G Hahn; Martin Raithel
Journal:  Dig Dis Sci       Date:  2007-06-12       Impact factor: 3.199

5.  Ethanol Mediates Cell Cycle Arrest and Apoptosis in SK-N-SH Neuroblastoma Cells.

Authors:  Maria Lee; Byoung-Joon Song; Yongil Kwon
Journal:  J Cancer Prev       Date:  2014-03

Review 6.  Molecular Basis of Alcohol-Related Gastric and Colon Cancer.

Authors:  Hye-Kyung Na; Ja Young Lee
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

7.  Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis.

Authors:  Benyam P Yoseph; Elise Breed; Christian E Overgaard; Christina J Ward; Zhe Liang; Maylene E Wagener; Daniel R Lexcen; Elizabeth R Lusczek; Greg J Beilman; Eileen M Burd; Alton B Farris; David M Guidot; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.